People

Pritam  Thapa

Postdoctoral Fellow

Department of Pharmaceutical Sciences

Phone (405) 271-6593  x47223
Fax (405) 271-7505
Office   CPB 351
Email pritam-thapa@ouhsc.edu

Selected Publications & Presentations

  1. Kwon HB, Park C, Jeon KH, Lee E, Park SE, Jun KY, Kadayat TM, Thapa P, Karki R, Na Y, Park MS, Rho SB, Lee ES, Kwon Y. A series of novel terpyridine-skeleton molecule derivants inhibit tumor growth and metastatis by targeting topoisomerases. J Med Chem 2015; 58: 1100-1122.
  2. Das BC, Thapa P, Karki R, Das S, Mahapatra S, Liu TC, Torregroza I, Wallace DP, Kambhampati S, Van Veldhuizen P, Verma A, Ray SK, Evans T. Reinoic acid signaling pathways in development and disease. Bioorg Med Chem 2014; 22: 673-683.
  3. Thapa P, Karki R, Yoo HY, Lee E, Jeon KH, Na Y, Cho WJ, Kwon Y, Lee ES. 2,4-diaryl-5, 6-dihydro-1, 10-phenanthroline and 2,4-diaryl-5, 6-dihydrothieno [2,3-h] quinolone derivatives for topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study. Bioorg Chem 2012; 40: 67-78.
  4. Thapa P, Karki R, Yun M, Kadayat TM, Lee E, Kwon HB, Na Y, Cho WJ, Kim ND, Jeong BS, Kwon Y, Lee ES. Design, synthesis and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety. Eur J Med Chem 2012; 52: 123-136.
  5. Thapa P, Karki R, Choi H, Choi JH, Yun M, Jeong BS, Jung MJ, Nam JM, Na Y, Cho WJ, Kwon Y, Lee ES. Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Bioorg Med Chem 2010; 18: 2245-2254.